Shenzhen Huada Gene Technology Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Shenzhen Huada Gene Technology Co., Ltd. - overview
Established
1999
Location
Shenzhen, Guangdong, China
Primary Industry
Biotechnology
About
Founded in 1999 and based in Shenzhen, China, Shenzhen Huada Gene Technology Co. , Ltd. is an operator of genome-sequencing centers. The firm primarily engages in the provision of commercial scientific, and research and development services in genomics.
Current Investors
Taikang Life, SB China Venture Capital, Greenwoods Asset Management
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Molecular Science, Genetics & Gene Therapy
Website
www.bgi.com/
Company Stage
Mature
Total Amount Raised
Subscriber access only
Shenzhen Huada Gene Technology Co., Ltd. - financials
| Fiscal Year Ended | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 1,131,981,848 | 1,318,703,623.7 | 1,711,498,253.7 | 2,087,628,841.2 | 2,531,629,221.2 | 2,793,734,804.4 | 8,386,922,285.5 | 6,766,137,315.1 | 7,053,150,771.5 | - | - | - |
| % Revenue Growth (YoY) | - | 16.5% | 29.8% | 22.0% | 21.3% | 10.4% | 200.2% | (19.3%) | 4.2% | - | - | - |
| EBITDA (USD) | 179,089,600 | 431,075,600 | 521,712,200 | 641,819,290.6 | 647,556,274.5 | 587,384,657.3 | 3,039,181,547.9 | 2,101,612,274.7 | 1,445,042,030.5 | - | - | - |
| Operating Income (USD) | 53,559,907.2 | 303,907,756.4 | 382,343,040.6 | 506,526,673.8 | 455,641,962.5 | 323,570,943.9 | 2,710,962,831.3 | 1,822,834,803.7 | 1,087,910,170.4 | - | - | - |
| Operating Margin | 4.7% | 23.0% | 22.3% | 24.3% | 18.0% | 11.6% | 32.3% | 26.9% | 15.4% | - | - | - |
| % EBITDA Margin | 15.8% | 32.7% | 30.5% | 30.7% | 25.6% | 21.0% | 36.2% | 31.1% | 20.5% | - | - | - |
| NET Income (USD) | 58,529,764 | 272,055,201.9 | 350,017,461.4 | 423,686,096.2 | 407,844,229.2 | 278,519,084.7 | 2,102,052,355.1 | 1,477,698,603.6 | 809,285,542.9 | - | - | - |
| % Net Margin | 5.2% | 20.6% | 20.5% | 20.3% | 16.1% | 10.0% | 25.1% | 21.8% | 11.5% | - | - | - |
Shenzhen Huada Gene Technology Co., Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Announced | Chongqing Xinyichan Life Technology Co., Ltd. | - | ||||||||
| Add-on | Completed | Litaier Pharm | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.